LBRX · Lb Pharmaceuticals Inc
$32.31
+1.41 (+4.56%)
At close · Jul 21
Market Cap
$926.54M
Shares
28.68M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$25.21M
+60.1%
FY2025
Diluted EPS
-$3.13
+98.2%
FY2025
Operating Cash Flow
-$35.21M
+33.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| — | $16.74M | $51.17M | |
| — | $13.66M | $13.66M | |
| — | $321K | $91K | |
| — | $30.4M | $64.83M | |
| — | $3.92M | $1.72M | |
| — | $5.2M | $1.73M | |
| — | -$25.2M | -$63.1M | |
| — | $1000 | $1000 | |
| -$38.95M | -$25.21M | -$63.1M | |
| — | -$25.21K | -$63.1K | |
| — | -$25.15M | -$63.27M | |
| USD/shares | — | -$3.13 | -$176.15 |
| USD/shares | — | -$3.13 | -$176.15 |
| shares | — | 8.05M | 358.23K |
| shares | — | 8.05M | 358.23K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.